December 20, 2021
Article
Two different doses of the company's mRNA vaccine were found to increase antibodies by up to 83-fold.
December 13, 2021
A novel digital pill was 98% effective in tracking daily HIV PrEP adherence.
HPV vaccination decreases cervical cancer incidence and mortality, but it is most effective in young women and girls.
December 11, 2021
New cohort data from VA medical centers provide more evidence of a correlate between antibody levels and vaccine effectiveness for mRNA vaccines.
December 10, 2021
The CDC updated its HIV PrEP guidelines, including a recommendation that doctors talk to all sexually active adults about HIV prevention and prescribe PrEP to anyone who asks for it.
December 07, 2021
Merck announced an enrollment pause in 2 of their stage 3 clinical trials for once-monthly oral islatravir for HIV PrEP. Enrolled participants will continue receiving study medicine.
December 02, 2021
Only 1 in 3 heterosexually active adults is aware of HIV PrEP, and this is even lower among Hispanic/Latinx men and women.
November 16, 2021
A new report suggests FDA and CDC deliberations may result in booster doses of the mRNA vaccine becoming available by this weekend.
November 04, 2021
The Biden administration is also setting mandates for health care workers in facilities receiving federal aid.
November 02, 2021
Video
Suzan Walters, PhD, discusses her research on the PrEP care continuum among people who inject drugs in rural versus urban settings.
